Skip to content
Peptides Info

storage

Freeze–Thaw Cycles and Aliquoting: Damage Mechanisms and Sizing Practice

Freeze–thaw damage is applied by the transition, not by the cold. Reference on the physical stresses, the variables under control, and how to size aliquots so the question of cycle count never arises.

There is no general number, and a source that offers one is guessing: freeze–thaw tolerance is a property of a specific sequence in a specific formulation at a specific concentration, established by testing that material rather than by rule of thumb. The working answer is to make the question irrelevant — divide the solution into single-use aliquots when it is prepared, thaw one, discard what is left. The damage mechanisms are physical and well described: freeze concentration, a shift in buffer pH, and an expanded ice–water interface, applied on every cycle regardless of how briefly the material was frozen 13.

What a freeze–thaw cycle does physically

Freezing a peptide solution is not a uniform arrest of everything in it. Pure ice nucleates and grows first, and solutes are excluded from the crystal lattice as it forms, driven into the shrinking volume of liquid between the crystals. That unfrozen fraction persists until the system reaches the glass transition of the maximally freeze-concentrated solution, and while it persists it is a different chemical environment from the one prepared at the bench 1. Several stresses act there, together rather than in sequence.

StressPhysical originEffect on the peptide
Freeze concentrationSolutes excluded from growing ice concentrate into the shrinking unfrozen fractionTransient concentration far above nominal; self-association and aggregation far more probable
pH shiftBuffer components reach their solubility limits at different points, so one leaves solution firstWorking pH moves during freezing; the peptide meets conditions never present at the bench
Ice–water interfaceCrystal growth creates a large new internal surfaceAdsorption and unfolding at that surface, then aggregation
Excipient crystallisationStabilisers and salts may crystallise out of the concentrated fractionLoss of the protective additive when it is most needed
Stresses applied during a single freeze–thaw cycle, and what each acts on.

The material is not simply cold. While the sample is part-frozen it sits at high concentration, at a pH it was not formulated for, against a large new surface 13. Aggregation is a common endpoint of all three and is not undone by warming: the loss is to soluble intact material, whether or not anything visible appears 2.

The phosphate example

Sodium phosphate is the standard worked demonstration of the pH shift. A phosphate buffer holds monobasic and dibasic species in a ratio that sets the pH. On freezing, the dibasic salt is the less soluble and reaches its solubility limit first in the concentrating fraction, crystallising out while the monobasic species stays in solution. The ratio shifts and the unfrozen liquid acidifies — by a margin large enough to take the peptide outside the range the formulation was chosen for 13.

Three points follow. The behaviour belongs to the buffer rather than to the peptide, so it applies to anything held in phosphate. It occurs on every freeze, and warming afterwards does not reverse an excursion already experienced. And it is invisible: pH is not measurable in the frozen state by ordinary means, so a reading before freezing and one after thawing will agree, and neither reports the value the material actually saw.

Other buffers shift too, in a direction set by which component leaves solution first, and several are better behaved than phosphate 3. That choice belongs to preparation; the handling consequence is only that phosphate carries a pH excursion on every cycle as well as a concentration one.

Why the damage is per-cycle

Chemistry in a stable frozen solid is slow because molecular mobility is low. The stresses above are not applied by the frozen state; they are applied by the transitions into and out of it. A sample frozen once and held for a year passes through the concentrated intermediate twice. One thawed and refrozen weekly passes through it a hundred times in that year, at the same temperature, with the same appearance.

This is why "how long can it be kept?" and "how many times can it be thawed?" are different questions, and why the second usually governs. It also explains the pattern of failure: loss is stepwise rather than sudden, each step a handling event, and the material behaves acceptably until accumulated loss crosses whatever threshold the analysis notices 2. Nothing on the tube records the count, and a tally somebody must remember to increment will eventually be wrong — which is the argument for aliquoting rather than counting.

Freezing rate, thaw rate and the intermediate state

Two rates are under direct control, and both set how long the sample spends part-frozen — the interval in which every stress above is applied 3. Freezing rate is the more ambiguous. Rapid freezing clears the concentrated intermediate quickly but produces many small crystals and so more ice surface; slow freezing produces fewer, larger crystals and less interface, but holds the material in the concentrated fraction for longer. Which trade favours a given sequence is not settled in general terms 13. What is not in dispute is that a tube left to freeze over hours in a warm, freshly loaded freezer is handled badly on both.

Thawing is the less ambiguous half, and the guidance is simple: thaw rapidly. A hand-warm bath clears a small volume in a minute or two; a tube left on the bench takes far longer and holds the sample in the concentrated, pH-shifted intermediate throughout. Remove it the moment the last ice disappears. Mix gently as it thaws, by inversion or swirling. Do not vortex: vigorous agitation introduces an air–water interface with much the same aggregating effect as the ice–water one it replaces 2.

VariableDirection of effectControl
Number of cyclesDamage accumulates per cycle. The dominant variable, by a wide marginAliquot to single use. One cycle per aliquot
Thaw rateSlower thaw means longer in the concentrated, pH-shifted intermediateHand-warm bath; remove when the last ice disappears
Freezing rateRapid freezing shortens the intermediate but raises ice surface area; slow freezing reverses bothFreeze small volumes in a unit already at temperature
Agitation during thawGentle mixing disperses the concentrated fraction; vigorous mixing adds an air–water interfaceInvert or swirl. Never vortex
Buffer systemSets size and direction of the pH excursion on freezingChosen at preparation. Phosphate is the worst-behaved common choice
Cryoprotectant or surfactantReduces aggregation from freeze concentration and from interfaces respectivelyFormulation decision; must precede the first freeze
Container and headspaceAdsorptive surfaces and a large air volume both remove material from solutionMatch tube size to aliquot volume; choose the material deliberately
Variables in a freeze–thaw cycle: direction of effect and the control available.

Cryoprotectants and excipients, in outline

Formulations resist freeze–thaw stress rather than avoiding it. Disaccharides — sucrose and trehalose — and polyols such as glycerol and sorbitol are the standard additions 13. Two mechanisms are generally offered: preferential exclusion in the liquid state, where the additive is excluded from the hydration layer and so makes the unfolded conformation unfavourable; and, as water is removed into ice, substitution for it at polar surface groups. Non-ionic surfactants address a different problem — they occupy interfaces so the peptide does not 23.

The handling point is a negative one: all of this is decided before the first freeze. Adding a stabiliser to a solution already cycled recovers nothing, and aggregates already formed will not be dissociated by it 2. Additive choice also interacts with the intended analysis. Read this as background to a formulation, not a prompt to add anything.

Aliquot sizing

Aliquoting is the whole of good freeze–thaw practice; everything above is background to it. The rule is short and the discipline lies in accepting its cost: size each aliquot to a single use, and never return a thawed one to the freezer.

Single use means the volume a working session consumes plus what the transfer loses — not what one measurement needs, and not a convenient round number. Size generously enough that an aliquot is never short: the failure mode of one sized too tightly is a second aliquot thawed to finish the work, which converts a one-cycle scheme into a two-cycle one.

The material cost is real and should be accepted explicitly: residue is left in every tube, and adsorption to the wall scales with the number of containers 4. That loss is bounded, visible and countable in advance. The loss from repeated cycling is none of those things.

  1. Decide the aliquot volume before reconstituting, from what a single session consumes plus transfer loss. Decide it on paper, not while holding a full tube.
  2. Label every tube before filling: identity, concentration, date, aliquot number. Label a dry tube at ambient temperature, with ink and adhesive rated for the storage temperature.
  3. Reconstitute and mix the bulk gently to homogeneity. Concentration differences between tubes are fixed at this step.
  4. Dispense the whole set promptly from that single mixed bulk, rather than leaving it at ambient while tubes are filled slowly.
  5. Fill to leave modest headspace — enough for expansion on freezing, not so much that the air volume dominates.
  6. Cap firmly and check each closure. A tube that opens in the freezer loses its aliquot and contaminates the box.
  7. Freeze the set at once, upright and separated in a rack, in a unit already at temperature.
  8. Log the set: date, number of aliquots, volume, concentration, and location to slot level.
  9. In use, remove one aliquot. Thaw it rapidly with gentle agitation, bring it to ambient temperature, mix, use it in that session.
  10. Discard what remains of a thawed aliquot. Do not refreeze it, and do not hold it at 2–8 °C as a compromise unless solution stability over that interval is known.

Containers, headspace and labels

Container choice matters more for peptides than the cost of a tube suggests. Peptides adsorb to container surfaces, and the proportion lost that way rises as concentration falls and as the surface-to-volume ratio rises — exactly the regime a small aliquot occupies 4. Material bound to a wall is not in the solution being pipetted, so the effect presents as a concentration below the one calculated, and it is largest where it is least likely to be suspected 4.

  • Match the tube to the volume. A small aliquot in an oversized tube presents more wall and more headspace than the same volume in a tube sized for it.
  • Choose the material deliberately rather than by what is nearest. Adsorption differs between plastics, between plastic and glass, and between treated and untreated surfaces.
  • Leave headspace for expansion — water expands on freezing, and a tube filled to its cap can distort the closure or crack — but keep it modest, since a large air volume is a large air–water interface throughout the thaw.
  • Prefer screw caps with an O-ring at or below −20 °C. Snap caps loosen under repeated thermal cycling.
  • Test the labelling scheme on a sacrificial tube through a full cycle. Adhesive lifts at low temperature; ink lifts when a frosted tube is handled with a gloved hand.
  • Store aliquots upright and separated. A tube that tips before freezing fully redistributes solution into the cap.

Freeze–thaw loss is a handling variable, not a property of the material to be endured. The mechanisms are applied at the transitions, and their number is set by how the solution was divided on the day it was prepared. An aliquot scheme decided in ten minutes removes the question of cycle tolerance permanently; a stock tube returned to the freezer after each use raises it every week and never answers it 23.

References

  1. Rational design of stable lyophilized protein formulations: some practical advicePharmaceutical Research, 1997
  2. Protein aggregation—pathways and influencing factorsInternational Journal of Pharmaceutics, 2010
  3. Instability, stabilization, and formulation of liquid protein pharmaceuticalsInternational Journal of Pharmaceutics, 1999
  4. The importance of using the optimal plasticware and glassware in studies involving peptidesAnalytical Biochemistry, 2011